Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Capital Expenditures (2020 - 2026)

GeneDx Holdings has reported Capital Expenditures over the past 7 years, most recently at $5.9 million for Q1 2026.

  • Quarterly Capital Expenditures rose 169.23% to $5.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Mar 2026, up 129.92% year-over-year, with the annual reading at $6.3 million for FY2025, 142.05% up from the prior year.
  • Capital Expenditures was $5.9 million for Q1 2026 at GeneDx Holdings, up from -$8.4 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $8.9 million in Q3 2025 and troughed at -$8.4 million in Q4 2025.
  • The 5-year median for Capital Expenditures is $759000.0 (2023), against an average of $878352.9.
  • The largest YoY upside for Capital Expenditures was 6029.31% in 2025 against a maximum downside of 5474.36% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at -$6.5 million in 2022, then skyrocketed by 83.28% to -$1.1 million in 2023, then skyrocketed by 114.36% to $156000.0 in 2024, then tumbled by 5474.36% to -$8.4 million in 2025, then surged by 170.55% to $5.9 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Capital Expenditures are $5.9 million (Q1 2026), -$8.4 million (Q4 2025), and $8.9 million (Q3 2025).